Chronic asymptomatic inflammation of the prostate type IV and carcinoma of the prostate: Is there a correlation?

Scandinavian Journal of Urology

Volumn 47, Issue 3, 2013, Pages 230-235

  Engelhardt, P F ^a   Brustmann, H ^a   Seklehner, S ^a   Riedl, C R ^a  

^a Landesklinikum Thermenregion Baden ^*  (Austria)

Author keywords

Adenocarcinoma of the prostate; Benign prostatic hyperplasia; Chronic prostatic inflammation; Inflammation; Prostate cancer

Indexed keywords

CHOLESTEROL; PROSTATE SPECIFIC ANTIGEN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; BODY MASS; CANCER STAGING; CANCER SURGERY; CHRONIC INFLAMMATION; CLINICAL EVALUATION; CONTROLLED STUDY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATE VOLUME; PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC; TRANSURETHRAL RESECTION;

ADENOCARCINOMA; AGED; CHRONIC DISEASE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; PROSTATITIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84880340739     PISSN: 21681805     EISSN: 21681813     Source Type: Journal    
DOI: 10.3109/00365599.2012.733961     Document Type: Article

References (24)

1. Jamal A, Tiwari RC, Murray T, Ghafoor A. Cancer statistics 2007. CA Cancer J Clin 2007;57:43-66
2. Hudson T, Denis LJ. Europa Uomo: The European Prostate CancerCoalition.RecentResultsCancerRes2007;175:267-71
3. Konig JE, Senge T, Alhoff EP, Konig W. Analysis of the inflammatory network in benign prostate hyperplasia and prostatic cancer. Prostate 2004;58:121-31
4. ShahR,MucciNR,AminA,MacoskaJA,RubinMA.Prostatic hyperplasia and the prostate gland: Neoplastic precursor or innocent bystander? Am J Pathol 2001;158:1767-72
5. De Marzo AM, March VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis. Am J Pathol 1999;155:1985-90
6. Sciarra A, Di Silverio F, Salciccia S, Gomez AAG, Gentilucci A, Gentile V. Inflammation and chronic prostatic diseases: Evidence for a link? Eur Urol 2007;52:964-72
7. De Nunzio C, Kramer G, Marberger M, Nelson W, Schröder F, Sciarra A, et al. The controversial relationship between benign prostatic hyperplasia and prostate cancer: The role of inflammation. Eur Urol 2011;60:106-17
8. Fleshner NE, Klotz LH. Diet, androgens, oxidative stress and prostate cancer susceptibility. Am J Pathol 1998;17:325-31
9. Billis A, Magna LA. Inflammatory atrophy of the prostate. Prevalence and significance. Arch Pathol Lab Med 2003;127: 840-9
10. Putz MJ, De Marzo AM. Morphologic transitions between proliferative inflammatory atrophy and high grade prostatic intraepithelial neoplasia. Urology 2000;56:828-34
11. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-9
12. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003;3:276-83
13. Irani J, Levillian P, Gouion JM, Bon D, Dore B, Aubert J. Inflammation in benign prostatic hyperplasia: Correlation with prostatic specific antigen value. J Urol 1997;157: 1301-3
14. Rosen RC, Riley A, Wagner G, Osterloh JH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-8
15. Elkahawji JE, Zhong W, Bushman W. Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis. Prostate 2007;67:14-21
16. Martinon F, Petrilli V, Myor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 2006;440:237-41
17. Nelson WG, De Marzo AM, Isaacs WB. Prostate cancer. N Engl J Med 2003;349:366-81
18. Naber K, Weidner W. Chronic prostatitis: An infectious diseases? J Antimicrob Chemother 2000;46:157-61
19. Dennis L, Lynch CF, Tornes JC. Epidemiologic association between prostatitis and prostate cancer. Urology 2002;60: 78-83
20. Karakiewicz PI, Banayoun S, Begin LR. Chronic inflammation is negatively associated with prostate cancer and high grade intraepithelial neoplasia on needle biopsy. Int J Clin Pract 2007;71:425-30
21. Goldstraw MA, Fitzpatrick JM, Kirby RS. What is the role of inflammation in the pathogenesis of prostate cancer? BJU Int 2007;15:1-2
22. Di Silverio F, Gentile V, de Matteis A. Distribution of inflammation, premalignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: A retrospective analysis. Eur Urol 2003;43:164-75
23. Nickel JG. Prostatic inflammation in BPH: The third component? Can J Urol 1994;1:1-4
24. Crawford ED, Wilsson SS, Roehrborn CG. MTPOS Study Group. Baseline factors as predictors of clinical progression of benign prostate hyperplasia in men treated with placebo. J Urol 2006;175:1422-7